Asr Vermogensbeheer N.V. Exact Sciences Corp Transaction History
Asr Vermogensbeheer N.V.
- $7.71 Trillion
- Q2 2025
A detailed history of Asr Vermogensbeheer N.V. transactions in Exact Sciences Corp stock. As of the latest transaction made, Asr Vermogensbeheer N.V. holds 17,143 shares of EXAS stock, worth $831,264. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,143
Previous 15,120
13.38%
Holding current value
$831,264
Previous $655 Million
39.18%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding EXAS
# of Institutions
644Shares Held
157MCall Options Held
1.83MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$865 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$855 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$606 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$585 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$321 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.58B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...